BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Biohaven Announces First Patient Treated in Clinical Research Collaboration At Rutgers Cancer Institute

  Biohaven announced a clinical collaboration today with Drs. Ann Silk and James Goydos at the Rutgers Cancer Institute of New Jersey.

  October 30, 2017

   · 

  5 min read
• NeuroCog Trials Awarded NIH Grant to Validate Performance-Based Measure of Functioning in MCI Alzheimer’s Disease

  NeuroCog Trials today announced it received a 2017 Fast Track grant from the NIH to study the validation of a performance-based measure of functioning in Mild Cognitive Impairment and early ALZ’s disease using NCT’s proprietary technology, the Virtual Reality Functional Capacity Assessment Tool.

  October 30, 2017

   · 

  2 min read
• Business

  Regen BioPharma Announces Former Eli Lilly Executive and Current CVS Board Member will Lead Newly Formed Business Advisory Board

  Regen BioPharma announced that former Eli Lilly executive Jean-Pierre Millon will serve as chairman of its newly formed business advisory board.

  October 30, 2017

   · 

  4 min read
• Business

  Castle Creek Pharma Announces Hiring of Dr. Amir Tavakkol as Executive VP and Chief Development Officer

  Castle Creek Pharma today announced that Amir Tavakkol, Ph.D., has joined the company as executive VP and chief development officer who will report directly to Michael Derby, co-founder and CEO at CCP.

  October 30, 2017

   · 

  2 min read
• Cardiome Announces Commercial Launch of Xydalba in Three New European Geographies

  Cardiome today announced that it has initiated the commercial launch of Xydalba in Sweden, Finland and the Republic of Ireland.

  October 30, 2017

   · 

  7 min read
• Business

  Varian Names New Chief People Officer, SVP HR

  Varian today announced it has named Terilyn Juarez Monroe as Chief People Officer, senior VP, Human Resources effective October 30, 2017.

  October 30, 2017

   · 

  1 min read
• Pharm Country

  Takeda and the New York Academy of Sciences Announce Innovators in Science Award Honorees

  The Winner of the Senior Scientist Award is Shigetada Nakanishi, M.D., Ph.D., Director, Suntory Foundation for Life Sciences Bioorganic Research Institute in Japan.

  October 30, 2017

   · 

  6 min read
• Drug Development

  Syros Presents New Preclinical PK and PD Data for SY-1365, Its First-in-Class Selective CDK7 Inhibitor, at AACR-NCI-EORTC Conference

  Syros Pharmaceuticals announced that new preclinical pharmacodynamic and pharmacokinetic data providing a rationale for the twice weekly dosing regimen currently being used in the ongoing Phase 1 clinical trial of SY-1365.

  October 30, 2017

   · 

  7 min read
• FDA

  Novaliq’s NovaTears Treatment for Evaporative Dry Eye Disease Launches in New Zealand and Receives Registrational Approval in Australia

  NovaTears immediately stabilizes the lipid layer without causing vision blurring.

  October 30, 2017

   · 

  4 min read
• Drug Development

  Eyenovia Publication of EYE 102 Phase II Results Demonstrates Strong Pharmacodynamic Effect, Tolerability and Reduced Systemic Exposure of High-Precision Micro-dosing compared to Conventional Eyedroppers

  Eyenovia’s micro-dose delivery of topical phenylephrine achieves comparable dilation results with a dose one-quarter the volume of a conventional pipette eye dropper.

  October 30, 2017

   · 

  4 min read